急性冠状动脉综合征合并慢性肾脏病患者治疗策略  

Progress in treatment strategies of patients with acute coronary syndrome and chronic kidney disease

作　　者：刘金明[1] 李芳[1] 谢亚囡[1] 

机构地区：[1]河北医科大学第二医院心内科,河北石家庄050000

出　　处：《临床荟萃》2016年第6期600-605,共6页Clinical Focus

摘　　要：慢性肾脏病(CKD)是心血管疾病(CVD)的独立危险因素,而CVD也是CKD死亡的最主要原因。由于肾脏病患者出血风险增加,使得针对急性冠状动脉综合征(ACS)治疗的基础药物及治疗措施使用率降低,尤其是进行早期经皮冠状动脉介入术的治疗率低,进而使得ACS合并CKD的发病率及病死率增高。本文就ACS合并CKD的发病机制、临床特点及治疗策略作一综述。Chronic kidney disease（CKD）is an independent risk factor of cardiovascular disease（CVD）,and CVD is the main cause of death in CKD.Because of the increased risk of bleeding in patients with CKD and acute coronary syndrome（ACS）,the basic treatment of drugs and other therapeutic measures are reduced,especially percutaneous coronary intervention treatment,which is associated with increased morbidity and mortality.This review systematically focuses on the pathogenesis,clinical characteristics and treatment strategies in patients with ACS and CKD.

关 键 词：急性冠状动脉综合征 肾疾病 经皮冠状动脉介入术 

分 类 号：R542.2[医药卫生—心血管疾病]